| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |